GE HealthCare Technologies logo
GE HealthCare Technologies
GEHC | NASDAQ
Chart Builder DCF Calculator
$82.96
-$0.06 (-0.07%)
At close: Nov 16, 2026, 4:00 PM ET
$82.99
+$0.03 (+0.04%)
After-hours: Nov 16, 2026, 7:36 PM ET

GE HealthCare Technologies Company Profile

Company profile explained

Company Profile

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Key Executives

Name Position
Jeannette Bankes President & Chief Executive Officer of Patient Care Solutions
Kevin Michael O'Neill President & Chief Executive Officer of Pharmaceutical Diagnostics
Peter J. Arduini President, Chief Executive Officer & Director
Adam Holton Chief People Officer
Jahid Khandaker Chief Information Officer
William K. Grogan Chief Financial Officer
Carolynne Borders Chief Investor Relations Officer
Catherine Estrampes Chief Commercial & Growth Officer and Head of Global Markets
Frank R. Jimenez General Counsel & Corporate Secretary
George Andrew Newcomb Controller & Chief Accounting Officer
Rana Strellis Chief Corporate Marketing & Communications Officer
Taha Kass-Hout Chief Science & Technology Officer

Latest SEC Filings

Date Type Title
Oct 28, 2026 10-Q Quarterly Report
Oct 28, 2026 8-K Current Report
Sep 22, 2026 8-K Current Report
Sep 16, 2026 4 Filing
Sep 16, 2026 3 Filing
Sep 04, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 04, 2026 4 Filing
View All SEC Filings ➞
GE HealthCare Technologies
GE HealthCare Technologies logo
Country United States
IPO Date Dec 15, 2022
Industry Medical - Devices
Sector Healthcare
Employees 54,000
CEO Peter J. Arduini

Contact Details

500 West Monroe Street Chicago, Illinois 60661 United States

Stock Details

Ticker Symbol GEHC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001932393
CUSIP Number 36266G107
ISIN Number US36266G1076
SIC Code 3844

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.